Virgilio Salvo, MD

Recent Publications

1. Physicochemicalmodi¢cation of the excretion product of Saccharomyces cerevisiae killer strains results in fungicidal activity against Candida albicans and Tricophyton mentagrophytes. Nelson Bracesco, Virgilio A. Salvo, Francisco M. Carrau & Elia Nunes. FEMSLE, 2006.
    

2. he p38 MAPK Stimulates Estrogen-Mediated Transcription and Proliferation Through the Phosphorylation and Potentiation of the p160 Coactivator Glucocorticoid receptor interacting protein 1. Daniel E. Frigo, Aninda Basu, Erica N. Nierth-Simpson, Christopher B. Weldon, Christine M. Dugan, Steven Elliott, Bridgette M. Collins-Burow, Virgilio A. Salvo, Yun Zhu, Lilia I. Melnik, Gabriela N. Lopez, Peter J. Kushner, Tyler Curiel, Brian G. Rowan, John A. McLachlan, and Matthew E. Burow,. Mol. Endocrinology 20 (5): 971-983, (2006).
    

3. Antiestrogenic Glyceollins Suppress Human Breast and Ovarian Carcinoma Tumorigenesis. Virgilo A. Salvo, Stephen M. Boué, Juan P. Fonseca, Steven Elliott, Cynthia Corbitt, Bridgette M. Collins-Burow, Christopher B. Weldon, Tyler J. Curiel, Betty Y. Shih, Carol Carter-Wientjes, Charles Wood, Thomas B. Clarkson, Paul Erhardt, Barbara Beckman, John A. McLachlan, Thomas E. Cleveland Matthew E. Burow Submitted to Clinical Cancer Research, 2006;12(23) 7159-7163, December 2006.
    

4. Bracesco N, Salvo VA, Rocah S, Dell M, Carrau F, Nunes E.Analysis of a putative protection against free radicals by grape derivatives (Vitis vinifera L. Cv. Tannat) in Saccharomyces cerevisiaeRev Argent Microbiol. 2007 Jan-Mar;39(1):4-10.
    

5. Progressive Decreases in Plasma Octreotide Levels in Patients Receiving Chronic Octreotide LAR Therapy,Woltering, EA1, Salvo, A.1, O’Dorisio, TM2, Lyons, J. III1, Li, G3, Zhou, Y3, , Vinik, AI4, Mamikunian, P5, and Mamikunian, G5 and Go, VLW3 Pancreas, January 2008.